Literature DB >> 30771365

Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back.

Chiara Demartini1, Rosaria Greco1, Anna Maria Zanaboni2, Grazia Sances1, Roberto De Icco2, David Borsook3, Cristina Tassorelli4.   

Abstract

Migraine is a disease for which there is still no defined pathophysiological etiology and few translational models. The organic nitrate nitroglycerin has been in use as an experimental model of migraine in both human and animal studies for several years. The drug produces a number of effects within the head, that includes blood vessels, nerves and brain areas that may produce a response similar to a migraine attack in predisposed subjects. A better understanding of the nature of these changes and how well they parallel a true migraine attack would allow for a translational model to better understand some of the mechanisms involved in the generation of a migraine attack. The present review summarizes the known body of knowledge of nitroglycerin effects evaluated in humans and animals as it relates to potential mechanisms associated with migraine headaches.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Animal model; Migraine; Migraneurs; Nitroglycerin

Mesh:

Substances:

Year:  2019        PMID: 30771365     DOI: 10.1016/j.pneurobio.2019.02.002

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  22 in total

1.  Transient receptor potential melastatin 8 is required for nitroglycerin- and calcitonin gene-related peptide-induced migraine-like pain behaviors in mice.

Authors:  Chao Wei; Brian Kim; David D McKemy
Journal:  Pain       Date:  2022-03-29       Impact factor: 7.926

2.  TRPM8 contributes to sex dimorphism by promoting recovery of normal sensitivity in a mouse model of chronic migraine.

Authors:  David Alarcón-Alarcón; David Cabañero; Jorge de Andrés-López; Magdalena Nikolaeva-Koleva; Simona Giorgi; Gregorio Fernández-Ballester; Asia Fernández-Carvajal; Antonio Ferrer-Montiel
Journal:  Nat Commun       Date:  2022-10-22       Impact factor: 17.694

3.  Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.

Authors:  Zachariah Bertels; Harinder Singh; Isaac Dripps; Kendra Siegersma; Alycia F Tipton; Wiktor D Witkowski; Zoie Sheets; Pal Shah; Catherine Conway; Elizaveta Mangutov; Mei Ao; Valentina Petukhova; Bhargava Karumudi; Pavel A Petukhov; Serapio M Baca; Mark M Rasenick; Amynah A Pradhan
Journal:  Elife       Date:  2021-04-15       Impact factor: 8.140

4.  Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache.

Authors:  Zhaohua Guo; Katherine Czerpaniak; Jintao Zhang; Yu-Qing Cao
Journal:  Pain       Date:  2021-05-01       Impact factor: 7.926

5.  Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders.

Authors:  Jintao Zhang; Katherine Czerpaniak; Liang Huang; Xuemei Liu; Megan E Cloud; Jacqueline Unsinger; Richard S Hotchkiss; Daizong Li; Yu-Qing Cao
Journal:  Pain       Date:  2020-06       Impact factor: 7.926

Review 6.  Animal models of migraine and experimental techniques used to examine trigeminal sensory processing.

Authors:  Andrea M Harriott; Lauren C Strother; Marta Vila-Pueyo; Philip R Holland
Journal:  J Headache Pain       Date:  2019-08-29       Impact factor: 7.277

7.  Experimentally induced spinal nociceptive sensitization increases with migraine frequency: a single-blind controlled study.

Authors:  Roberto De Icco; Armando Perrotta; Valentina Grillo; Giuseppe Cosentino; Grazia Sances; Giorgio Sandrini; Cristina Tassorelli
Journal:  Pain       Date:  2020-02       Impact factor: 7.926

8.  α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia.

Authors:  Hung-Ruei Tzeng; Ming Tatt Lee; Pi-Chuan Fan; Daniel E Knutson; Tzu-Hsuan Lai; Werner Sieghart; James Cook; Lih-Chu Chiou
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

9.  Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine.

Authors:  Anna P Andreou; Charlotte Leese; Rosaria Greco; Chiara Demartini; Eve Corrie; Deniz Simsek; Anna Zanaboni; Ksenia Koroleva; Joseph O Lloyd; Giorgio Lambru; Ciara Doran; Oleg Gafurov; Elizabeth Seward; Rashid Giniatullin; Cristina Tassorelli; Bazbek Davletov
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 7.620

Review 10.  The Emerging Role of Mechanosensitive Piezo Channels in Migraine Pain.

Authors:  Adriana Della Pietra; Nikita Mikhailov; Rashid Giniatullin
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.